Integrated single-cell and spatial analysis identifies T cell exhaustion and adhesion signatures in early follicular lymphoma transformation
Abstract
Abstract INTRODUCTION. Germinal center (GC) lymphomas, including follicular lymphoma (FL) and diffuse large B cell lymphoma (DLBCL), arise from B cells at distinct GC stages and display molecular and clinical heterogeneity. FL transformation is associated with poor outcomes, yet predictive biomarkers at diagnosis remain unclear. We integrated single-cell and spatial transcriptomics to dissect tumor and microenvironmental heterogeneity and identify features associated with early FL transformation. METHODS. Five lymph node samples collected at diagnosis were analyzed using single-cell DNA sequencing (scDNA-seq, Mission Bio), single-cell RNA sequencing (scRNA-seq, 10x Genomics), and spatial transcriptomics (Visium HD, 10x Genomics). The cohort included 3 DLBCL cases (1 GCB, 2 ABC) and 2 FL cases: 1 non-transformed (ntFL) and 1 that underwent histological transformation 16 months after diagnosis (tFL), sampled during the indolent FL phase. RESULTS. Single-cell RNA-seq analysis revealed meaningful heterogeneity among malignant B cells across GC lymphoma subtypes. ntFL was enriched in light-zone GC B cells, characterized by overexpression of cytokine signaling genes. In contrast, malignant B cells from tFL and GCB DLBCL shared a transcriptional profile suggestive of a common ancestral precursor (intermediate dark zone/light zone GC B cells with strong BCR signaling). ABC DLBCL samples were enriched in pre-memory B and pre-plasma cells. Within the tumor microenvironment (TME), canonical exhaustion markers were more highly expressed in CD8+ Teff and CD4+ Treg cells in DLBCL and tFL compared to ntFL. CD4+ Tfh cells overexpressed adhesion-related genes, with significantly higher expression in DLBCL and tFL. Based on these findings, we defined two transcriptional signatures: an exhaustion signature (CD8+ Teff and CD4+ Treg) and an adhesion signature (CD4+ Tfh). Both signatures were significantly enriched in tFL versus ntFL (exhaustion: p<2.22x10-16; adhesion: p=0.0042). These findings were validated in an independent FL cohort (Sarkozy et al. 2024), where both signatures remained significantly elevated in tFL, particularly in early transformation cases (exhaustion: p=0.0045; adhesion: p=2.4x10-9). To investigate the mutational landscape underlying these transcriptomic findings, we performed scDNA-seq analysis. In 4 patients, we identified mutations in chromatin-modifying and oncogenic genes. In GCB and tFL, KMT2D mutations were clonal first hits, while EZH2 (tFL) and ATM (GCB) were found as secondary hits. A second scDNA-seq analysis identified clonal hematopoiesis-related mutations in non-B TME cells, with 2 or 3 mutations per sample in TET2, ASXL1, or DNMT3A. To assess whether spatial architecture contributes to these transcriptional profiles, we integrated previous data from a spatial perspective using Visium HD. We included FFPE lymph node blocks from ntFL, GCB DLBCL, and tFL at diagnosis (tFL-FL) and transformation (tFL-DLBCL). Using gene signatures derived from our paired scRNA-seq dataset, we calculated cell type scores for each 8x8 mm bin. Each bin was assigned to the cell type with the highest score. In ntFL, B cell bins were frequently surrounded by myeloid cell bins, whereas in tFL-FL, the neighborhood of B cell bins was enriched in CD8+ T and exhausted T cell bins. B cell bins in tFL-DLBCL and GCB samples showed broader interactions with TME bins (CD4+ T and exhausted T) and fewer B-B contacts, reflecting diffuse growth patterns. Exhausted CD4+ Treg and CD8+ Teff bins were more enriched around B cell bins in tFL-FL versus ntFL (Z-score: 0.39 vs. 0.27) and further increased after transformation (Z-score: 0.49 vs. 0.39). Ligand-receptor interaction analysis confirmed stronger interactions between CD4⁺ Tfh bins and B cell bins in tFL-FL versus ntFL (e.g., CD40LG-CD40: 0.40 vs. 0.26; CXCL13-CXCR5: 0.76 vs. 0.65; CD2-CD58: 0.27 vs. 0.22).CONCLUSIONS. These findings suggest that ntFL and tFL represent distinct biological entities, while tFL and GCB DLBCL share a common ancestral precursor. The combined expansion of exhausted T cells and CD4⁺ Tfh with an adhesion phenotype, together with their increased spatial interaction with malignant B cells, defines an immunosuppressive niche with potential prognostic value for identifying FL patients at high risk of early transformation. The detection of clonal hematopoiesis-associated mutations in non-B TME cells across all samples suggests a potential role in lymphomagenesis.
Article Details
Authors (21)
Sofia Huerga
8Clínica Universidad de Navarra, Pamplona, Spain
Beñat Ariceta
1Center for Applied Medical Research, Universidad de Navarra, Navarra Medical Research Institute, Pamplona, Spain
Paula Aguirre-Ruiz
Patxi San Martín-Uriz
1Center for Applied Medical Research, Universidad de Navarra, Navarra Medical Research Institute, Pamplona, Spain
Sarai Sarvide
2Centre for Applied Medical Research (CIMA), Hematology and Oncology Program, Pamplona, Spain
Álvaro López-Janeiro
3Clínica Universidad de Navarra, Department of Pathological Anatomy, Pamplona, Spain
Diego Alignani
Aitziber Lopez
Teresa Ezponda
7Department of Oncology-Hematology, CIMA Universidad de Navarra-IDISNA-CCUN. Centro de Investigación Biomédica en Red de Cáncer, CIBERONC. Clínica Universidad de Navarra, Pamplona, Spain
Maria Rocio Figueroa Mora
1Clínica Universidad de Navarra, Hematology Department, Pamplona, Spain
Carlos Grande
Ana Alfonso
1Clínica Universidad de Navarra, Hematology Department, Pamplona, Spain
Esther Pena
1Clínica Universidad de Navarra, Hematology Department, Pamplona, Spain
Santiago Browne
8Clínica Universidad de Navarra, Pamplona, Spain
Marta Abengozar
3Clínica Universidad de Navarra, Department of Pathological Anatomy, Pamplona, Spain
Ramón Robledano
3Clínica Universidad de Navarra, Department of Pathological Anatomy, Pamplona, Spain
Amaia Vilas-Zornoza
Sergio Roa
2Centre for Applied Medical Research (CIMA), Hematology and Oncology Program, Pamplona, Spain
José A. Martinez-Climent
Felipe Prosper
Miguel Ángel Canales Albendea
1Clínica Universidad de Navarra, Hematology Department, Pamplona, Spain